{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:34:27Z","timestamp":1793835267357,"version":"4.6.1"},"reference-count":151,"publisher":"Xia & He Publishing","issue":"2","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.xiahepublishing.com"],"crossmark-restriction":false},"short-container-title":["J Clin Transl Hepatol"],"published-print":{"date-parts":[[2022,4,28]]},"DOI":"10.14218\/jcth.2021.00178","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T11:05:47Z","timestamp":1634641547000},"page":"329-338","update-policy":"https:\/\/doi.org\/10.14218\/crossmark_policy","source":"Crossref","is-referenced-by-count":204,"title":["Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver"],"prefix":"10.14218","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9293-2811","authenticated-orcid":false,"given":"Eda","family":"Kaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4518-5283","authenticated-orcid":false,"given":"Yusuf","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"issue":"6","key":"key20211019041148_JCTH-D-21-00178-b1","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"11","key":"key20211019041148_JCTH-D-21-00178-b3","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b4","article-title":"Non-alcoholic Fatty Liver Disease: A Global Public Health Issue.In:Faintuch J,Faintuch S,editors","author":"Kaya","journal-title":"Obesity and Diabetes.Springer,Cham.2020,pp.321-333"},{"issue":"7","key":"key20211019041148_JCTH-D-21-00178-b5","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"4","key":"key20211019041148_JCTH-D-21-00178-b7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/17474124.2021.1860019","article-title":"A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD","volume":"15","author":"Yilmaz","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b8","doi-asserted-by":"crossref","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","volume":"111S","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12944-020-01288-6","article-title":"Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis","volume":"19","author":"Liu","year":"2020","journal-title":"Lipids Health Dis"},{"issue":"2","key":"key20211019041148_JCTH-D-21-00178-b10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5009\/gnl19069","article-title":"Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease","volume":"14","author":"Li","year":"2020","journal-title":"Gut Liver"},{"issue":"7","key":"key20211019041148_JCTH-D-21-00178-b11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/biomedicines8070229","article-title":"Depression and Cognitive Impairment-Extrahepatic Manifestations of NAFLD and NASH","volume":"8","author":"Colognesi","year":"2020","journal-title":"Biomedicines"},{"key":"key20211019041148_JCTH-D-21-00178-b12","doi-asserted-by":"crossref","DOI":"10.2174\/1573402116999201209203534","article-title":"Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver","author":"Godinez-Leiva","year":"2020","journal-title":"Curr Hypertens Rev"},{"issue":"9","key":"key20211019041148_JCTH-D-21-00178-b13","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Lin","year":"2020","journal-title":"Liver Int"},{"issue":"6","key":"key20211019041148_JCTH-D-21-00178-b14","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/liv.14828","article-title":"Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population","volume":"41","author":"Ciardullo","year":"2021","journal-title":"Liver Int"},{"key":"key20211019041148_JCTH-D-21-00178-b15","doi-asserted-by":"crossref","first-page":"693507","DOI":"10.3389\/fmed.2021.693507","article-title":"NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?-Results From NHANES III","volume":"8","author":"Huang","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"key20211019041148_JCTH-D-21-00178-b16","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD","volume":"40","author":"Yamamura","year":"2020","journal-title":"Liver Int"},{"issue":"10","key":"key20211019041148_JCTH-D-21-00178-b17","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.cgh.2020.10.046","article-title":"Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease","volume":"19","author":"Wong","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b18","first-page":"S1542-3565(21)00149-X","article-title":"Impact of the New Metabolic-Associated Fatty Liver Disease (MAFLD) on NAFLD Patients Classification in Italy","author":"Angelico","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"key20211019041148_JCTH-D-21-00178-b19","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","article-title":"A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease","volume":"378","author":"Abul-Husn","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"key20211019041148_JCTH-D-21-00178-b20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: Clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"issue":"12","key":"key20211019041148_JCTH-D-21-00178-b21","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4254\/wjh.v12.i12.1228","article-title":"Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population","volume":"12","author":"Lee","year":"2020","journal-title":"World J Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b22","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2147\/CIA.S254740","article-title":"FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population","volume":"15","author":"Gu","year":"2020","journal-title":"Clin Interv Aging"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b23","first-page":"79","article-title":"Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice?","volume":"3","author":"Demirtas","year":"2020","journal-title":"Hepatology Forum"},{"issue":"6","key":"key20211019041148_JCTH-D-21-00178-b24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/obr.12407","article-title":"Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies","volume":"17","author":"Li","year":"2016","journal-title":"Obes Rev"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cld.2013.09.018","article-title":"Obesity-associated nonalcoholic fatty liver disease","volume":"18","author":"Yilmaz","year":"2014","journal-title":"Clin Liver Dis"},{"issue":"9765","key":"key20211019041148_JCTH-D-21-00178-b26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","article-title":"National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9\u20221 million participants","volume":"377","author":"Finucane","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"key20211019041148_JCTH-D-21-00178-b28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fendo.2014.00164","article-title":"Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments","volume":"5","author":"Sasaki","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.soard.2014.06.015","article-title":"Liver disease in the morbidly obese: a review of 1000 consecutive patients undergoing weight loss surgery","volume":"11","author":"Subichin","year":"2015","journal-title":"Surg Obes Relat Dis"},{"issue":"7","key":"key20211019041148_JCTH-D-21-00178-b30","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/hep4.1519","article-title":"Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta-Analysis","volume":"4","author":"Young","year":"2020","journal-title":"Hepatol Commun"},{"issue":"4","key":"key20211019041148_JCTH-D-21-00178-b31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4103\/2230-8210.113758","article-title":"Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fatty liver disease?","volume":"17","author":"Kumar","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"key20211019041148_JCTH-D-21-00178-b32","article-title":"World Health Organization. Obesity: preventing and managing the global epidemic. Report on a WHO consultation on obesity, Geneva, 3-5 June, 1997. WHO\/NUT\/NCD\/98.1. Technical Report Series Number 894. Geneva, Switzerland: World Health Organization; 2000"},{"issue":"6","key":"key20211019041148_JCTH-D-21-00178-b33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/cld.930","article-title":"NAFLD in Lean Asians","volume":"16","author":"Eslam","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"3","key":"key20211019041148_JCTH-D-21-00178-b34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/00365521.2014.983160","article-title":"Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels","volume":"50","author":"Akyuz","year":"2015","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"key20211019041148_JCTH-D-21-00178-b35","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"issue":"4","key":"key20211019041148_JCTH-D-21-00178-b36","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b37","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"key":"key20211019041148_JCTH-D-21-00178-b38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13104-018-3212-1","article-title":"Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis","volume":"11","author":"Bernhardt","year":"2018","journal-title":"BMC Res Notes"},{"issue":"10","key":"key20211019041148_JCTH-D-21-00178-b39","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/MEG.0000000000001656","article-title":"Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic fatty liver disease patients","volume":"32","author":"Hamurcu Varol","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b40","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s13679-019-00345-1","article-title":"Nonalcoholic fatty liver disease and obesity treatment","volume":"8","author":"Brunner","year":"2019","journal-title":"Curr Obes Rep"},{"key":"key20211019041148_JCTH-D-21-00178-b41","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.metabol.2016.01.001","article-title":"Non-alcoholic fatty liver disease and diabetes","volume":"65","author":"Hazlehurst","year":"2016","journal-title":"Metabolism"},{"key":"key20211019041148_JCTH-D-21-00178-b42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrendo.2017.173","article-title":"Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus","volume":"14","author":"Targher","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"key20211019041148_JCTH-D-21-00178-b43","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/apt.15830","article-title":"Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices","volume":"52","author":"Younossi","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"11-12","key":"key20211019041148_JCTH-D-21-00178-b44","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/apt.16034","article-title":"Letter: the use of Fibrosis-4 score in primary care and diabetology practices-Occam\u2019s razor applied to advanced fibrosis screening","volume":"52","author":"Yilmaz","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"key20211019041148_JCTH-D-21-00178-b45","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr Rev"},{"issue":"4","key":"key20211019041148_JCTH-D-21-00178-b46","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"issue":"3","key":"key20211019041148_JCTH-D-21-00178-b47","first-page":"101","article-title":"A disquiet find: The clinical and histological characteristics of patients with biopsy-proven non-alcoholic fatty liver disease in the absence of insulin resistance","volume":"1","author":"Demirtas","year":"2020","journal-title":"Hepatology Forum"},{"issue":"8","key":"key20211019041148_JCTH-D-21-00178-b48","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/jgh.14595","article-title":"Japan Study Group of Nonalcoholic Fatty Liver Disease. HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholicfatty liver disease","volume":"34","author":"Fujii","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"issue":"11","key":"key20211019041148_JCTH-D-21-00178-b49","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cld.2017.08.010","article-title":"Nonalcoholic Fatty Liver Disease and Metabolic Syndrome","volume":"22","author":"Kim","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"5","key":"key20211019041148_JCTH-D-21-00178-b51","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis","volume":"31","author":"Ballestri","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b52","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jhep.2016.09.022","article-title":"Bi-directional analysis between fatty liver and cardiovascular disease risk factors","volume":"66","author":"Ma","year":"2017","journal-title":"J Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b53","first-page":"1547","article-title":"Fibrosis stage is the strongest predictor fordisease-specific mortality in NAFLD after up to 33 years of follow-up.Hepatology","volume":"61","author":"Ekstedt","year":"2015"},{"key":"key20211019041148_JCTH-D-21-00178-b54","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fattyliver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"key20211019041148_JCTH-D-21-00178-b55","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b56","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2013.07.052","article-title":"A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?","volume":"230","author":"Oni","year":"2013","journal-title":"Atherosclerosis"},{"key":"key20211019041148_JCTH-D-21-00178-b57","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.25855","article-title":"Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events","volume":"56","author":"VanWagner","year":"2012","journal-title":"Hepatology"},{"key":"key20211019041148_JCTH-D-21-00178-b58","first-page":"79","article-title":"Frequency of cardiovascular events and effect on survival in liver transplant recipients for cirrhosis due to alcoholic or nonalcoholic steatohepatitis","volume":"14","author":"Piazza","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"key20211019041148_JCTH-D-21-00178-b59","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/jgh.14856","article-title":"Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study","volume":"35","author":"Sinn","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b60","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"issue":"7","key":"key20211019041148_JCTH-D-21-00178-b61","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/apt.15660","article-title":"Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease","volume":"51","author":"Henson","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"key20211019041148_JCTH-D-21-00178-b62","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","article-title":"Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"key20211019041148_JCTH-D-21-00178-b63","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12072-021-10157-y","article-title":"Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?","volume":"15","author":"Guerreiro","year":"2021","journal-title":"Hepatol Int"},{"issue":"7","key":"key20211019041148_JCTH-D-21-00178-b64","doi-asserted-by":"crossref","first-page":"e13519","DOI":"10.1111\/eci.13519","article-title":"Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches","volume":"51","author":"Dongiovanni","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"key20211019041148_JCTH-D-21-00178-b65","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41575-018-0010-0","article-title":"Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease","volume":"15","author":"Anstee","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b66","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/liv.14044","article-title":"Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: an updated meta-analysis","volume":"39","author":"Mantovani","year":"2019","journal-title":"Liver Int"},{"key":"key20211019041148_JCTH-D-21-00178-b67","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/liv.14461","article-title":"Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation","volume":"40","author":"Cai","year":"2020","journal-title":"Liver Int"},{"key":"key20211019041148_JCTH-D-21-00178-b68","doi-asserted-by":"crossref","first-page":"e001820","DOI":"10.1161\/JAHA.115.001820","article-title":"Nonalcoholic fatty liver disease is associated with qt prolongation in the general population","volume":"4","author":"Hung","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"key20211019041148_JCTH-D-21-00178-b69","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2337\/dc16-0091","article-title":"Nonalcoholic fatty liver disease is associated with ventricular arrhythmias in patients with type 2 diabetes referred for clinically indicated 24-hour holter monitoring","volume":"39","author":"Mantovani","year":"2016","journal-title":"Diabetes Care"},{"issue":"8","key":"key20211019041148_JCTH-D-21-00178-b70","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.metabol.2015.04.003","article-title":"Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease","volume":"64","author":"Mantovani","year":"2015","journal-title":"Metabolism"},{"issue":"4","key":"key20211019041148_JCTH-D-21-00178-b71","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jhep.2017.11.023","article-title":"Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients","volume":"68","author":"Lee","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b72","doi-asserted-by":"crossref","first-page":"e000598","DOI":"10.1136\/openhrt-2017-000598","article-title":"Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure","volume":"4","author":"Sato","year":"2017","journal-title":"Open Heart"},{"key":"key20211019041148_JCTH-D-21-00178-b73","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2014.11.030","article-title":"Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease","volume":"62","author":"Petta","year":"2015","journal-title":"J Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b74","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/1755-5922.12145","article-title":"Nonalcoholic steatohepatitis score is an independent predictor of right ventricular dysfunction in patients with nonalcoholic fatty liver disease","volume":"33","author":"Sunbul","year":"2015","journal-title":"Cardiovasc Ther"},{"issue":"7","key":"key20211019041148_JCTH-D-21-00178-b75","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"key20211019041148_JCTH-D-21-00178-b76","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1089\/met.2019.0115","article-title":"High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation","volume":"18","author":"Lechner","year":"2020","journal-title":"Metab Syndr Relat Disord"},{"key":"key20211019041148_JCTH-D-21-00178-b77","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3389\/fimmu.2019.02163","article-title":"Adipocytes Directly Affect Coronary Artery Disease Pathogenesis via Induction of Adipokine and Cytokine Imbalances","volume":"10","author":"Gruzdeva","year":"2019","journal-title":"Front Immunol"},{"issue":"12","key":"key20211019041148_JCTH-D-21-00178-b78","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/ng.3977","article-title":"Exome-wide association study of plasma lipids in >300,000 individuals","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"key":"key20211019041148_JCTH-D-21-00178-b79","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J Hepatol"},{"issue":"5","key":"key20211019041148_JCTH-D-21-00178-b80","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrneph.2017.16","article-title":"Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease","volume":"13","author":"Targher","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b81","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1038\/s41598-018-23014-0","article-title":"Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study","volume":"8","author":"Jang","year":"2018","journal-title":"Sci Rep"},{"key":"key20211019041148_JCTH-D-21-00178-b82","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/joim.12964","article-title":"Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: A propensity-matched cohort study","volume":"286","author":"Park","year":"2019","journal-title":"J Intern Med"},{"issue":"8","key":"key20211019041148_JCTH-D-21-00178-b83","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1177\/2050640620944098","article-title":"Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease","volume":"8","author":"Kaps","year":"2020","journal-title":"United European Gastroenterol J"},{"issue":"1 Suppl","key":"key20211019041148_JCTH-D-21-00178-b84","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"issue":"6","key":"key20211019041148_JCTH-D-21-00178-b85","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3390\/jcm9061635","article-title":"Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study","volume":"9","author":"Akahane","year":"2020","journal-title":"J Clin Med"},{"issue":"3","key":"key20211019041148_JCTH-D-21-00178-b86","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00125-007-0897-4","article-title":"Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative\/laser-treated retinopathy in type 2 diabetic patients","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"issue":"7","key":"key20211019041148_JCTH-D-21-00178-b87","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00125-010-1720-1","article-title":"Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients","volume":"53","author":"Targher","year":"2010","journal-title":"Diabetologia"},{"issue":"12","key":"key20211019041148_JCTH-D-21-00178-b88","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.2215\/CJN.05050610","article-title":"Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis","volume":"5","author":"Targher","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20211019041148_JCTH-D-21-00178-b89","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","article-title":"Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis","volume":"79","author":"Mantovani","year":"2018","journal-title":"Metabolism"},{"key":"key20211019041148_JCTH-D-21-00178-b90","first-page":"496","article-title":"Higher NAFLD fibrosis score is associated with impaired eGFR","volume":"3)","author":"Hsieh","journal-title":"J Formos Med Assoc 2020;119(1 Pt"},{"issue":"4","key":"key20211019041148_JCTH-D-21-00178-b91","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MEG.0000000000000531","article-title":"Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals","volume":"28","author":"Choudhary","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"key20211019041148_JCTH-D-21-00178-b92","doi-asserted-by":"crossref","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS Med"},{"issue":"4","key":"key20211019041148_JCTH-D-21-00178-b93","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.diabet.2019.11.003","article-title":"Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD","volume":"46","author":"Sun","year":"2020","journal-title":"Diabetes Metab"},{"issue":"9","key":"key20211019041148_JCTH-D-21-00178-b94","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.metabol.2009.12.012","article-title":"Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis","volume":"59","author":"Yilmaz","year":"2010","journal-title":"Metabolism"},{"key":"key20211019041148_JCTH-D-21-00178-b95","doi-asserted-by":"crossref","first-page":"154433","DOI":"10.1016\/j.metabol.2020.154433","article-title":"MAFLD and risk of CKD","volume":"115","author":"Sun","year":"2021","journal-title":"Metabolism"},{"issue":"5","key":"key20211019041148_JCTH-D-21-00178-b96","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/ijms17050717","article-title":"Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers","volume":"17","author":"Sanna","year":"2016","journal-title":"Int J Mol Sci"},{"key":"key20211019041148_JCTH-D-21-00178-b97","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann Med"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b98","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2017.09.012","article-title":"Association between non-alcoholic fatty liver disease and cancer incidence rate","volume":"68","author":"Kim","year":"2018","journal-title":"J Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b99","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jhep.2019.08.018","article-title":"The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study","volume":"71","author":"Allen","year":"2019","journal-title":"J Hepatol"},{"issue":"7","key":"key20211019041148_JCTH-D-21-00178-b100","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.dld.2018.12.024","article-title":"Nonalcoholic fatty liver disease is associated with breast cancer in nonobese women","volume":"51","author":"Kwak","year":"2019","journal-title":"Dig Liver Dis"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b101","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12944-020-01288-6","article-title":"Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis","volume":"19","author":"Liu","year":"2020","journal-title":"Lipids Health Dis"},{"key":"key20211019041148_JCTH-D-21-00178-b102","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12876-017-0696-4","article-title":"Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis","volume":"17","author":"Wongjarupong","year":"2017","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b103","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/MEG.0000000000001684","article-title":"Nonalcoholic fatty liver disease is associated with intrahepatic cholangiocarcinoma and not with extrahepatic form: definitive evidence from meta-analysis and trial sequential analysis","volume":"33","author":"Corrao","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2018.06.004","article-title":"Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis","volume":"87","author":"Mantovani","year":"2018","journal-title":"Metab Clin Exp"},{"key":"key20211019041148_JCTH-D-21-00178-b105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/17474124.2019.1580143","article-title":"The association between nonalcoholic fatty liver disease and risk of colorectal adenoma and cancer incident and recurrence: a meta-analysis of observational studies","volume":"13","author":"Jin","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b106","doi-asserted-by":"crossref","first-page":"e0245921","DOI":"10.1371\/journal.pone.0245921","article-title":"Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"16","author":"Lin","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"key20211019041148_JCTH-D-21-00178-b107","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.3390\/ijms22115462","article-title":"Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study","volume":"22","author":"Fukunaga","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7","key":"key20211019041148_JCTH-D-21-00178-b108","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/biomedicines8070229","article-title":"Depression and Cognitive Impairment-Extrahepatic Manifestations of NAFLD and NASH","volume":"8","author":"Colognesi","year":"2020","journal-title":"Biomedicines"},{"issue":"6","key":"key20211019041148_JCTH-D-21-00178-b109","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/jgh.12897","article-title":"Non-alcoholic fatty liver disease comorbid with major depressive disorder: The pathological features and poor therapeutic efficacy","volume":"30","author":"Tomeno","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"key20211019041148_JCTH-D-21-00178-b110","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/liv.12165","article-title":"Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease","volume":"33","author":"Youssef","year":"2013","journal-title":"Liver Int"},{"key":"key20211019041148_JCTH-D-21-00178-b111","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.psym.2012.09.005","article-title":"Association of Chronic Liver Disease with Depression: A Population-Based Study","volume":"54","author":"Lee","year":"2013","journal-title":"Psychosomatics"},{"key":"key20211019041148_JCTH-D-21-00178-b112","first-page":"9638797","article-title":"Cognitive Changes and Brain Volume Reduction in Patients with Nonalcoholic Fatty Liver Disease. Can","volume":"2018","author":"Filipovi\u0107","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"key20211019041148_JCTH-D-21-00178-b113","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/MEG.0000000000001131","article-title":"Cognitive assessment of patients with nonalcoholic fatty liver disease","volume":"30","author":"Celikbilek","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b114","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/liv.14161","article-title":"Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham Study","volume":"39","author":"Weinstein","year":"2019","journal-title":"Liver Int"},{"key":"key20211019041148_JCTH-D-21-00178-b115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-015-0467-5","article-title":"Non-alcoholic fatty liver disease induces signs of Alzheimer\u2019s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model","volume":"13","author":"Kim","year":"2016","journal-title":"J Neuroinflammation"},{"key":"key20211019041148_JCTH-D-21-00178-b116","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/metabo9050104","article-title":"Non-Alcoholic Fatty Liver Disease, and the Underlying Altered Fatty Acid Metabolism, Reveals Brain Hypoperfusion and Contributes to the Cognitive Decline in APP\/PS1 Mice","volume":"9","author":"Pin\u00e7on","year":"2019","journal-title":"Metabolites"},{"issue":"2","key":"key20211019041148_JCTH-D-21-00178-b117","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic Ovary Syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet Gynecol"},{"key":"key20211019041148_JCTH-D-21-00178-b118","doi-asserted-by":"crossref","first-page":"14172","DOI":"10.3748\/wjg.v20.i39.14172","article-title":"Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"20","author":"Kelley","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b119","doi-asserted-by":"crossref","first-page":"e000352","DOI":"10.1136\/bmjgast-2019-000352","article-title":"Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome","volume":"7","author":"Asfari","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12978-018-0519-2","article-title":"A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod Health"},{"issue":"10","key":"key20211019041148_JCTH-D-21-00178-b121","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key20211019041148_JCTH-D-21-00178-b122","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/liv.14279","article-title":"Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis","volume":"40","author":"Sarkar","year":"2020","journal-title":"Liver Int"},{"issue":"44","key":"key20211019041148_JCTH-D-21-00178-b123","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.3748\/wjg.v26.i44.7046","article-title":"Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome","volume":"26","author":"Shengir","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"10","key":"key20211019041148_JCTH-D-21-00178-b124","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3748\/wjg.v23.i10.1747","article-title":"Nonalcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle","volume":"23","author":"Poggiogalle","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"4","key":"key20211019041148_JCTH-D-21-00178-b125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2036.2012.05196.x","article-title":"Non-alcoholic fatty liver disease and osteoporosis\u2014clinical and molecular crosstalk","volume":"36","author":"Yilmaz","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"key20211019041148_JCTH-D-21-00178-b126","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12967-016-0766-3","article-title":"The association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women","volume":"14","author":"Xia","year":"2016","journal-title":"J Transl Med"},{"key":"key20211019041148_JCTH-D-21-00178-b127","doi-asserted-by":"crossref","first-page":"396545","DOI":"10.1155\/2013\/396545","article-title":"Low bone mineral density in chinese adults with nonalcoholic Fatty liver disease","volume":"2013","author":"Cui","year":"2013","journal-title":"Int J Endocrinol"},{"key":"key20211019041148_JCTH-D-21-00178-b128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","article-title":"Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis","volume":"66","author":"Koo","year":"2017","journal-title":"J Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b129","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/hep.30049","article-title":"Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: A 7-year longitudinal study","volume":"68","author":"Kim","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"key20211019041148_JCTH-D-21-00178-b130","first-page":"76","article-title":"Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations","volume":"8","author":"Kumar","year":"2020","journal-title":"J Clin Transl Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b131","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jhep.2012.02.027","article-title":"Non-alcoholic fatty liver disease across the spectrum of hypothyroidism","volume":"57","author":"Chung","year":"2012","journal-title":"J Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b132","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cgh.2020.02.039","article-title":"Longitudinal change in thyroid-stimulating hormone and risk of nonalcoholic fatty liver disease","volume":"19","author":"Chung","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"key20211019041148_JCTH-D-21-00178-b133","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.dld.2018.12.014","article-title":"Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?","volume":"51","author":"Lonardo","year":"2019","journal-title":"Dig Liver Dis"},{"key":"key20211019041148_JCTH-D-21-00178-b134","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s10620-011-2006-2","article-title":"Prevalence of hypothyroidism in nonalcoholic fatty liver disease","volume":"57","author":"Pagadala","year":"2012","journal-title":"Dig Dis Sci"},{"key":"key20211019041148_JCTH-D-21-00178-b135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2017.08.014","article-title":"Subclinical hypothyroidism and low-normal thyroid function are associated with nonalcoholic steatohepatitis and fibrosis","volume":"16","author":"Kim","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b136","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.cgh.2018.11.024","article-title":"Low-normal thyroid function is associated with advanced fibrosis among adults in the United States","volume":"17","author":"Kim","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"key20211019041148_JCTH-D-21-00178-b137","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1164\/rccm.201806-1109TR","article-title":"Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease","volume":"199","author":"Mesarwi","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"key20211019041148_JCTH-D-21-00178-b138","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.cgh.2016.04.037","article-title":"Institut de Recherche en Sant\u00e9 Respiratoire des Pays de la Loire Sleep Cohort Group. Association between severity of obstructive sleep apnea and blood markers of liver injury","volume":"14","author":"Trzepizur","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"key20211019041148_JCTH-D-21-00178-b139","doi-asserted-by":"crossref","first-page":"e32655","DOI":"10.5812\/hepatmon.32655","article-title":"Association Between the Severity of Nocturnal Hypoxia in Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Damage","volume":"15","author":"Cakmak","year":"2015","journal-title":"Hepat Mon"},{"issue":"8","key":"key20211019041148_JCTH-D-21-00178-b140","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/MEG.0000000000001920","article-title":"Obstructive sleep apnea and severity of nonalcoholic fatty liver disease","volume":"33","author":"Krolow","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b141","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3904\/kjim.2015.30.6.846","article-title":"Obstructive sleep apnea with excessive daytime sleepiness is associated with non-alcoholic fatty liver disease regardless of visceral fat","volume":"30","author":"Yu","year":"2015","journal-title":"Korean J Intern Med"},{"key":"key20211019041148_JCTH-D-21-00178-b142","doi-asserted-by":"crossref","first-page":"815721","DOI":"10.1155\/2015\/815721","article-title":"OSAS-related inflammatory mechanisms of liver injury in nonalcoholic fatty liver disease","volume":"2015","author":"Paschetta","year":"2015","journal-title":"Mediators Inflamm"},{"key":"key20211019041148_JCTH-D-21-00178-b143","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ultrasmedbio.2015.08.009","article-title":"Liver steatosis and fibrosis in OSA patients after long-term CPAP treatment: A preliminary ultrasound study","volume":"42","author":"Buttacavoli","year":"2016","journal-title":"Ultrasound Med Biol"},{"key":"key20211019041148_JCTH-D-21-00178-b144","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jhep.2009.06.008","article-title":"Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Miele","year":"2009","journal-title":"J Hepatol"},{"key":"key20211019041148_JCTH-D-21-00178-b145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/apt.13042","article-title":"The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic","volume":"41","author":"Roberts","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"key20211019041148_JCTH-D-21-00178-b146","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jdv.12847","article-title":"Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis","volume":"29","author":"Candia","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20211019041148_JCTH-D-21-00178-b147","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/ijms17020217","article-title":"Relationship between non-alcoholic fatty liver disease and psoriasis: a novel hepato-dermal axis?","volume":"17","author":"Mantovani","year":"2016","journal-title":"Int J Mol Sci"},{"key":"key20211019041148_JCTH-D-21-00178-b148","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.3748\/wjg.v23.i36.6571","article-title":"Nonalcoholic fatty liver disease: Evolving paradigms","volume":"23","author":"Lonardo","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"4","key":"key20211019041148_JCTH-D-21-00178-b149","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1111\/ajd.13098","article-title":"Nonalcoholic fatty liver disease puts patients with psoriasis at greater cardiovascular risk","volume":"60","author":"Romero-P\u00e9rez","year":"2019","journal-title":"Australas J Dermatol"},{"key":"key20211019041148_JCTH-D-21-00178-b150","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/jdv.13456","article-title":"Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis","volume":"30","author":"Gisondi","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"key20211019041148_JCTH-D-21-00178-b151","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2340\/00015555-2161","article-title":"Increased Prevalence of Advanced Liver Fibrosis in Patients with Psoriasis: A Cross-sectional Analysis from the Rotterdam Study","volume":"96","author":"van der Voort","year":"2016","journal-title":"Acta Derm Venereol"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:20:42Z","timestamp":1783707642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":151,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,3,2]]},"published-print":{"date-parts":[[2022,4,28]]}},"alternative-id":["10.14218\/JCTH.2021.00178"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2021.00178","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]}}}